Showing results (791-800 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|September 28, 2004
Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularizationE Corsini, M Gelati, C Calatozzolo, et al.Cancer Immunology, Immunotherapy : CII|September 1, 2004
Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?Karl-Johan MalmbergCancer Immunology, Immunotherapy : CII|November 12, 2003
A soluble single-chain T-cell receptor IL-2 fusion protein retains MHC-restricted peptide specificity and IL-2 bioactivityKimberlyn F Card, Shari A Price-Schiavi, Bai Liu, et al.Cancer Immunology, Immunotherapy : CII|November 19, 2003
Identification of a MHC class-II restricted epitope in carcinoembryonic antigenLei Shen, Roland Schroers, Juergen Hammer, et al.Cancer Immunology, Immunotherapy : CII|June 21, 2005
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanomaA N Alexander, M K Huelsmeyer, Ann Mitzey, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell linesZ Gazit, D W Weiss, D Shouval, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Interleukin-6 and renal cell cancer: production, regulation, and growth effectsA S Koo, C Armstrong, B Bochner, et al.Cancer Immunology, Immunotherapy : CII|January 30, 2004
Apoptosis pathways in cancer and cancer therapyKlaus-Michael DebatinCancer Immunology, Immunotherapy : CII|August 5, 2008
cDNA clone, prokaryotic expression and purification of human interleukin-13 receptor [alpha]2 chainWenqiao Yu, Zhipeng Su, Zhebao Wu, et al.Cancer Immunology, Immunotherapy : CII|August 5, 2008
Generation of a human IgM monoclonal antibody directed against HLA class II molecules: a potential agent in the treatment of haematological malignanciesBelén Díaz, Irene Sanjuan, Francisco Gambón, et al.Pageof 650